Krishnan A, Schneider CV, Hadi Y, Mukherjee D, et al. Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study. Diabetologia 2023 Dec 20. doi: 10.1007/s00125-023-06057.
PMID: 38117293